IRIS
CENCINI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.108
EU - Europa 2.738
AS - Asia 1.325
SA - Sud America 275
AF - Africa 42
OC - Oceania 4
Totale 7.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.073
RU - Federazione Russa 732
GB - Regno Unito 656
CN - Cina 476
SG - Singapore 442
IE - Irlanda 371
IT - Italia 261
BR - Brasile 235
SE - Svezia 200
UA - Ucraina 126
HK - Hong Kong 116
DE - Germania 106
FI - Finlandia 92
FR - Francia 89
VN - Vietnam 80
KR - Corea 54
IN - India 40
TR - Turchia 31
PL - Polonia 20
AR - Argentina 19
BD - Bangladesh 17
CA - Canada 17
JP - Giappone 17
AT - Austria 16
BE - Belgio 14
NL - Olanda 14
MX - Messico 12
CZ - Repubblica Ceca 10
KE - Kenya 10
ZA - Sudafrica 10
IQ - Iraq 8
SA - Arabia Saudita 8
IR - Iran 7
CI - Costa d'Avorio 6
ES - Italia 6
SK - Slovacchia (Repubblica Slovacca) 6
EC - Ecuador 5
MA - Marocco 5
PK - Pakistan 5
TN - Tunisia 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
ID - Indonesia 3
LT - Lituania 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
GR - Grecia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PA - Panama 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.492
Salva come PNG Salva come JPEG
Città #
Southend 594
Fairfield 389
Dublin 370
Dallas 334
Singapore 282
Ashburn 257
Moscow 216
Santa Clara 184
Chandler 170
Woodbridge 170
Houston 148
Beijing 145
Seattle 139
Ann Arbor 135
Wilmington 129
Cambridge 120
Hong Kong 114
Jacksonville 106
Hefei 83
Siena 77
Princeton 63
Dearborn 60
Seoul 54
Nanjing 44
Munich 42
Los Angeles 41
Turku 32
Izmir 28
New York 27
Lappeenranta 25
Menlo Park 25
Helsinki 24
Florence 23
Boardman 22
San Mateo 22
The Dalles 22
Ho Chi Minh City 21
Milan 18
Redondo Beach 18
Hanoi 17
São Paulo 17
Dong Ket 16
Brussels 14
Buffalo 14
Bengaluru 12
London 11
Nanchang 11
San Diego 11
Tianjin 11
Warsaw 11
Jinan 10
San Francisco 10
Chennai 9
Columbus 9
Nairobi 9
Rome 9
Shanghai 9
Shenyang 9
Atlanta 8
Belo Horizonte 8
Chicago 8
Denver 8
Johannesburg 8
Kunming 8
Tokyo 8
Vienna 8
Frankfurt am Main 7
Guangzhou 7
Portsmouth 7
Stockholm 7
Toronto 7
Abidjan 6
Brno 6
Brooklyn 6
Changsha 6
Hebei 6
Jiaxing 6
Lauterbourg 6
Montreal 6
Rio de Janeiro 6
Amsterdam 5
Boston 5
Phoenix 5
Baghdad 4
Bologna 4
Cagliari 4
Council Bluffs 4
Fuzhou 4
Kilburn 4
Maceió 4
New Delhi 4
Ningbo 4
Philadelphia 4
Poplar 4
Porto Alegre 4
Scarperia 4
Tehran 4
Bratislava 3
Cairo 3
Curitiba 3
Totale 5.225
Salva come PNG Salva come JPEG
Nome #
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 411
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 267
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 250
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large B-cell lymphoma 223
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 223
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma 219
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 219
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 209
New perspectives for patients with primary CNS lymphoma 207
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 203
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma 202
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab 200
Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximab 200
Primary Nasopharyngeal Hodgkin Lymphoma 198
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma 192
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 192
Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma 181
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas 179
Long term remission in a case of Plasmablastic lymphoma treated with COMP (Cyclophosphamide, Liposomal Doxorubicin, Vincristine, Prednisone) and Bortezomib 177
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 175
Therapeutic use of Brentuximab Vedotin In Cd30+ hematologic malignancies 172
Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma 170
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review 169
Prognostic role of m2 Tumour-Associated macrophages in lymphoproliferative disorders 167
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma 166
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma 165
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma 161
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma 147
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 142
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 131
How to manage early-stage follicular lymphoma 130
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 120
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? 118
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 109
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series 109
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 106
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications 103
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma 102
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract 96
Survival outcomes of patients with mantle cell lymphoma: a retrospective, 15-Year, real-life study 86
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) 85
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 83
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 78
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 77
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 75
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi 66
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi 63
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone 54
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) 52
Development and implementation of the International AIDA Network Castleman’s disease registry 41
Totale 7.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021538 0 0 0 0 0 80 77 111 62 82 64 62
2021/2022476 29 47 34 47 31 27 15 15 24 48 54 105
2022/2023636 34 62 85 73 77 130 17 43 63 6 24 22
2023/2024578 20 15 35 58 14 125 220 10 8 32 3 38
2024/20251.278 45 71 169 50 157 73 20 65 59 85 155 329
2025/20262.058 242 384 291 446 680 15 0 0 0 0 0 0
Totale 7.670